Physician profile
Arthur Wang
NPI 1184028367
$12,872.16
in general payments reported to CMS, 2019-2025
15 companies · $1,325 in 2025
The $1,325 reported for 2025 was more than what a typical Neurological Surgery provider received nationally (typical 2025 total: $604).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,479 · 2022: $1,810 · 2023: $7,317 · 2024: $941 · 2025: $1,325.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,952 · Travel and Lodging: $3,231 · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,952.42 |
| Travel and Lodging | $3,230.82 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,400.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $5,005.28 | 2021-2025 | Penumbra System, Benchmark, Red 72 |
| Globus Medical, INC. | $4,204.94 | 2021-2025 | Elsa, Corbel, Coalition Mis / Mis Ti |
| Medtronic, INC. | $1,106.10 | 2022-2025 | Pipeline, Axium Primetm, Solitaire X |
| Depuy Synthes Sales INC. | $843.41 | 2022-2025 | Embotrap, Trufill, Emboguard |
| Stryker Corporation | $448.42 | 2022-2023 | Trevo, Target, Actishield Cf |
| Microvention, INC. | $418.52 | 2022-2023 | Web Aneurysm Embolization System, Sofia 6f-131cm Str, Eric Retrieval Device |
| Siemens Medical Solutions USA, INC. | $241.24 | 2022-2025 | Artis Icono Biplane |
| Wenzel Spine, INC. | $170.63 | 2023 | Varilift |
| Mizuho America, INC. | $148.97 | 2022 | |
| Integra Lifesciences Corporation | $103.81 | 2023 | Cusa Clarity, Codman Hakim, Codman Certas |
| Novartis Pharmaceuticals Corporation | $51.69 | 2024 | |
| Abbott Laboratories | $47.77 | 2021 | |
| Cardiva Medical, INC. | $44.82 | 2023 | Cardiva Vascade Mvp Vvcs 6-12f, Cardiva Vascade 6/7f Vcs |
| Si-Bone, INC. | $23.90 | 2021 | |
| Aesculap, INC. | $12.66 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Arthur Wang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.